# Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy

> **NCT04885751** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Boramae Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Osteoarthritis
- Ankylosing Spondylitis
- Other Musculoskeletal Disorder
- Gastric Ulcer
- Enteritis
- NSAID-Associated Gastropathy
- NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy

## Interventions

- **DRUG:** Eupatilin
- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT04885751
- **Lead sponsor:** Seoul National University Boramae Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885751, "Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04885751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*